COMMENTARY:Role of High-density Lipoprotein Cholesterol in Renovascular Disease Treatment

Ischemic renal or renovascular disease is a reduction in glomerular filtration rate (GFR) and loss of renal parenchyma, caused by renal artery stenosis. Ischemic renal disease presents itself in the setting of extrarenal arteriosclerotic vascular disease, endothelial dysfunction, and also azotemia in older patients. Atherosclerotic renal artery disease is common in individuals with coronary artery disease and aortic and peripheral vascular disease.1 Risk factors for ischemic nephropathy are the same as those for coronary artery disease, so it seems that patients with renovascular disease die because of cardiovascular complications more than the progress to end-stage renal disease